# Bittium Biosignals signs supply agreement with Boston Scientific for ECG devices

Bittium Biosignals, a subsidiary of Bittium Corporation, has signed an agreement with Boston Scientific Cardiac Diagnostics to supply electrocardiogram measuring devices for cardiac arrhythmia monitoring, valued at approximately USD 30-45 million, with revenues accruing during 2025-2028.

- Type: Contract
- Announced: 2025-06-04
- Value: $45.0M
- Status: completed
- Products: electrocardiogram measuring devices, ECG sensors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bittium Biosignals Ltd](https://endata.com/companies/49832.md)
- [Boston Scientific Cardiac Diagnostics](https://endata.com/companies/85162.md) (customer)

## Sources

- [news.cision.com](https://news.cision.com/bittium-oyj/r/inside-information--bittium-corporation-s-subsidiary-bittium-biosignals-ltd--and-boston-scientific-h,c4159370), 2025-06-04: "The total value of the new agreement will be approximately USD 30–45 million, with revenues accruing during 2025–2028."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.